NewsAAAAI: GLP-1 Receptor Agonists Linked to Reduction in Asthma Exacerbation RiskHealthDay.comMarch 6, 2026
AAAAI: Omalizumab as Effective as Multifood Oral Immunotherapy for Individuals With Food AllergyMarch 6, 2026
NewsRecarbrio OK’d for Complicated Urinary Tract, Intra-Abdominal InfectionsHealthDay.comJuly 17, 2019